Mathieu Rougemont

1.2k total citations
17 papers, 667 citations indexed

About

Mathieu Rougemont is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Mathieu Rougemont has authored 17 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 8 papers in Epidemiology and 6 papers in Hepatology. Recurrent topics in Mathieu Rougemont's work include Hepatitis C virus research (6 papers), HIV/AIDS Research and Interventions (5 papers) and HIV Research and Treatment (4 papers). Mathieu Rougemont is often cited by papers focused on Hepatitis C virus research (6 papers), HIV/AIDS Research and Interventions (5 papers) and HIV Research and Treatment (4 papers). Mathieu Rougemont collaborates with scholars based in Switzerland, Slovakia and United Kingdom. Mathieu Rougemont's co-authors include Hans Peter Hinrikson, Katia Jaton, Roland Sahli, Jacques Billé, Béat Stoll, Nadia Elia, Enos Bernasconi, Andri Rauch, Roger D. Kouyos and Huldrych F. Günthard and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

Mathieu Rougemont

16 papers receiving 652 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mathieu Rougemont Switzerland 12 309 208 205 125 109 17 667
Pascal Cherpillod Switzerland 15 279 0.9× 337 1.6× 356 1.7× 52 0.4× 29 0.3× 25 860
Reinaldo de Menezes Martins Brazil 16 483 1.6× 412 2.0× 248 1.2× 40 0.3× 28 0.3× 33 812
G Sridharan India 17 127 0.4× 373 1.8× 274 1.3× 37 0.3× 83 0.8× 54 655
Loïc Chartier France 17 106 0.3× 503 2.4× 386 1.9× 89 0.7× 107 1.0× 23 893
Dennis Armando Bertolini Brazil 12 200 0.6× 114 0.5× 434 2.1× 33 0.3× 325 3.0× 54 653
Phillip LaRussa United States 10 63 0.2× 169 0.8× 682 3.3× 159 1.3× 67 0.6× 16 862
Solange Artimos de Oliveira Brazil 17 354 1.1× 676 3.3× 404 2.0× 94 0.8× 61 0.6× 77 1.1k
Laura J. Fehrs United States 9 103 0.3× 203 1.0× 591 2.9× 89 0.7× 70 0.6× 13 685
Guido Calleri Italy 17 332 1.1× 285 1.4× 337 1.6× 86 0.7× 303 2.8× 48 781
Aref Amirkhani Iran 12 159 0.5× 59 0.3× 207 1.0× 134 1.1× 52 0.5× 38 485

Countries citing papers authored by Mathieu Rougemont

Since Specialization
Citations

This map shows the geographic impact of Mathieu Rougemont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Rougemont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Rougemont more than expected).

Fields of papers citing papers by Mathieu Rougemont

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathieu Rougemont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Rougemont. The network helps show where Mathieu Rougemont may publish in the future.

Co-authorship network of co-authors of Mathieu Rougemont

This figure shows the co-authorship network connecting the top 25 collaborators of Mathieu Rougemont. A scholar is included among the top collaborators of Mathieu Rougemont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathieu Rougemont. Mathieu Rougemont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Künzler‐Heule, Patrizia, Axel J. Schmidt, Katharina Fierz, et al.. (2023). Exploring group differences in the response to a sexual risk reduction intervention to prevent hepatitis C virus reinfection in HIV-infected MSM: a mixed-methods study. AIDS Care. 36(4). 442–451. 2 indexed citations
2.
Hampel, Benjamin, Katharina Kusejko, Roger D. Kouyos, et al.. (2019). Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017. HIV Medicine. 21(4). 228–239. 51 indexed citations
3.
Braun, Dominique L., Benjamin Hampel, Eileen Martin, et al.. (2018). OUP accepted manuscript. Clinical Infectious Diseases. 68(4). 561–568. 12 indexed citations
4.
Béguelin, Charles, Enos Bernasconi, Jan Fehr, et al.. (2017). Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study. Liver International. 38(3). 424–431. 15 indexed citations
5.
Shepherd, Leah, Elżbieta Jabłonowska, Adriano Lazzarin, et al.. (2016). Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus–coinfected Individuals From 2001 to 2014: A Multicohort Study. Clinical Infectious Diseases. 63(6). 821–829. 32 indexed citations
6.
Shilaih, Mohaned, Alex Marzel, Alexandra Scherrer, et al.. (2016). Dually Active HIV/HBV Antiretrovirals as Protection Against Incident Hepatitis B Infections: Potential for Prophylaxis. The Journal of Infectious Diseases. 214(4). 599–606. 37 indexed citations
7.
Sauter, Rafael, Ruizhu Huang, Bruno Ledergerber, et al.. (2016). CD4/CD8 ratio and CD8 counts predict CD4 response in HIV-1-infected drug naive and in patients on cART. Medicine. 95(42). e5094–e5094. 22 indexed citations
8.
Kovari, Helen, Andri Rauch, Roger D. Kouyos, et al.. (2016). Hepatitis C Infection and the Risk of Non-Liver-Related Morbidity and Mortality in HIV-Infected Persons in the Swiss HIV Cohort Study. Clinical Infectious Diseases. 64(4). 490–497. 26 indexed citations
9.
Emonet, Stéphane, Stéphan Harbarth, Gesuèle Renzi, et al.. (2015). Rapid molecular diagnosis using femA mecA real-time PCR for staphylococcal bacteraemia improves early appropriate antibiotic prescribing: a randomised clinical trial. Antimicrobial Resistance and Infection Control. 4(S1). 2 indexed citations
10.
Rougemont, Mathieu, Cécile Delhumeau, Andrew Hill, et al.. (2015). Safety of zidovudine dose reduction in treatment‐naïve HIV infected patients. A randomized controlled study (MiniZID). HIV Medicine. 17(3). 206–215. 2 indexed citations
11.
Doco‐Lecompte, Thanh, et al.. (2014). Haemophagocytic syndrome and elevated EBV load as initial manifestation of Hodgkin lymphoma in a HIV patient: case report and review of the literature. Journal of the International AIDS Society. 17(4S3). 19650–19650. 2 indexed citations
12.
Agostinho, Américo, Gesuèle Renzi, Thomas Haustein, et al.. (2013). Epidemiology and acquisition of extended-spectrum beta-lactamase-producing Enterobacteriaceae in a septic orthopedic ward. SpringerPlus. 2(1). 91–91. 18 indexed citations
13.
Baumann, Pierre, et al.. (2013). [Recommendations for therapeutic monitoring of antidepressants].. PubMed. 9(377). 577–86.
14.
Rougemont, Mathieu, et al.. (2013). Capnocytophaga canimorsus Prosthetic Aortitis in an HIV-Positive Woman. Journal of Clinical Microbiology. 51(8). 2769–2771. 15 indexed citations
15.
Rougemont, Mathieu, et al.. (2009). Antiretroviral treatment adherence and its determinants in Sub-Saharan Africa: a prospective study at Yaounde Central Hospital, Cameroon. AIDS Research and Therapy. 6(1). 21–21. 78 indexed citations
16.
Rougemont, Mathieu, et al.. (2004). Detection of Four Plasmodium Species in Blood from Humans by 18S rRNA Gene Subunit-Based and Species-Specific Real-Time PCR Assays. Journal of Clinical Microbiology. 42(12). 5636–5643. 342 indexed citations
17.
Leriche, A, et al.. (1976). Urodynamic assessment of stress incontinence and its therapeutic implications.. PubMed. 142(3). 343–52. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pascal Cherpillod Breakdown of academic impact, for papers by Reinaldo de Menezes Martins Breakdown of academic impact, for papers by G Sridharan Breakdown of academic impact, for papers by Loïc Chartier Breakdown of academic impact, for papers by Dennis Armando Bertolini Breakdown of academic impact, for papers by Phillip LaRussa Breakdown of academic impact, for papers by Solange Artimos de Oliveira Breakdown of academic impact, for papers by Laura J. Fehrs Breakdown of academic impact, for papers by Guido Calleri Breakdown of academic impact, for papers by Aref Amirkhani
Rankless by CCL
2026